![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
In the league table of Japanese pharmaceutical company sales, Yamanouchi ranks fourth, behind Mitsubishi Kasei, Takeda and Sankyo. The company specialises in anti-infectives, cardiovascular, neurologicals, blood & clotting and musculoskeletal research, with 60 compounds reported to be in development. This article analyses the patenting strategy of the company and highlights key research projects.